What sector does Rpg Life Sciences Ltd belong to?

Rpg Life Sciences Ltd operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of RPGLIFE?

As of the latest available quote, RPGLIFE traded at ₹2,698.60. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of RPGLIFE?

Rpg Life Sciences Ltd has a price-to-earnings (P/E) ratio of about 37.31. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of RPGLIFE?

The market capitalisation of Rpg Life Sciences Ltd is approximately ₹4,463 Cr.

Is Rpg Life Sciences Ltd profitable?

For its latest reported financial year, Rpg Life Sciences Ltd recorded a net profit margin of about 16.24%.

Does RPGLIFE pay a dividend?

Rpg Life Sciences Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of RPGLIFE?

Rpg Life Sciences Ltd has a return on equity (ROE) of about 19.30%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of RPGLIFE?

Over the past 52 weeks, RPGLIFE has traded between a low of ₹1,733.00 and a high of ₹3,082.00.

Rpg Life Sciences Ltd

RPGLIFE NSE Healthcare Pharmaceuticals

₹2,698.60

-3.02%

Delayed · cached 15 min

Fair value analysis

RPGLIFE

Rpg Life Sciences Ltd

₹2,782.70

Close used for this calculation

₹1,487.14Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

37/100

Profitability10/25

Returns10/25

Balance Sheet13/25

Efficiency4/25

Growth0/25

Average

Quality radar

Consensus fair value

₹1,487.14

Above FV

▼ -46.6% against the close used

Model range ₹774.44 – ₹2,486.15

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹774.44Fair value₹1,487.14Bull₹2,486.15

FairClose

52-week traded range

52W low ₹1,744.0052W high ₹3,017.10

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Rpg Life Sciences Ltd closed at ₹2,782.70, 87.1% above the consensus fair value of ₹1,487.14 drawn from 7 valuation models.

Financial DNA score 37/100 — Average. P/E of 38.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹1,305.23

-53.1%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹774.44

-72.2%

√(22.5 × EPS × BVPS)

EPS=69.64, BVPS=382.76 · outside Graham range (P/E 38.2, P/B 7.3) — asset-light, treat as a rough floor

P/E Fair Value

₹2,486.15

-10.7%

EPS × 35.7x (sector P/E)

EPS=69.64, Sector P/E=35.7x

EV/EBITDA

₹1,041.25

-62.6%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=1.69B

Book Value (P/B)

₹891.30

-68.0%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=382.76, ROE=19.3%, g=3%, r=10%

Reverse DCF

₹2,782.70

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 16.5% | Historical: 0%

Margin of Safety

₹1,141.46

-59.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=1521.94, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer